[Search]
[by date] [by subject] [by continent]

Frontiers in Breast Cancer- A Comprehensive Symposium on Research, Diagnosis and Therapy.

Doubletree Hotel , 1750 Rockville Pike, Rockville, MD 20852 (~12min from NIH)
09/18/97 through 09/19/97

Invited Speakers: Keynote Speaker: Dr. Francis Collins, Dir. Natl. Human Genome Res. Inst.-NIH
Dr. Edison Liu, Dir. Clin. Sciences-NIH
Dr. Andrew Futreal, Duke Univ. Med. Ctr.
Dr. Jerry Shay, Univ. Texas Med. Ctr.
Dr. Brian Ward, VP, Myriad Genetics
Dr. Doug Dolginow, President, OncorMed
Dr. C. Malbon, State Univ. NY
Dr. Robert Clarke, Georgetown Med. Ctr.
Dr. Pat Steeg, NCI-NIH
Dr. Rachel Brem, Dir. Breast Imaging,Johns Hopkins Med. School
Dr. Frank Rauscher III, Chair, Mol. Oncology, Wistar Institute
Dr. Mark Danielsen, Georgetwon Med. Ctr.
Dr. M. John Kennedy, Johns Hopkins Med. Ctr.
Dr. Neil Holtzman, Dir. Genetics & Public Policy, Johns Hopkins Univ.
Dr. Gary Kelloff, Chief, Chemoprevention Branch-NCI
Dr. L. Wakefield, NCI
Dr. William Dooley, Johns Hopkins Med. School
Dr. Irene Gage, Johns Hopkins Med. School
Dr. Bernard Fisher, Natl. Surg. ADjuvant Breast Project (pending)
Lynn Godmilow, Dir. Genetic Testing Servive, U. Penn. Med.Ctr.
Mary Jo Ellis Kahn,, Dir. VA Breast Cancer Foundation
Susan Lucas, Natl. Breast Cancer Coalition

Program:
Keynote Address: The impact of the human genome project on the diagnosis and therapy of breast cancer
in the 21st century. - Dr. Francis Collins
SESSION I: GENETICS - molecular, clinical & public policy issues
*Genetic approaches to diagnosis - concepts & methods
*Discovery & charact. of Brca-1, -2, and the search for Brca-3
*Guidelines for ordering & interpreting genetic tests
*Genetic counseling, Informed consent,
*Physician education, Public Policy & Advocacy group issues
SESSION II: BIOCHEMISTRY & MOLECULAR BIOLOGY
*Using molecular markers to guide patient and disease stratification
*Telomerase, Tumor Suppressor, Oncogene studies
*Growth Factors, MAP Kinase, and Hormone receptor/resistance studies
*Molecular basis of breast cancer metastasis
*Elucidating protein-protein interactions for the Brca family
SESSION III: CLINICAL DETECTION & THERAPY
*Advances & controversies in radiologic evaluation, surgery & chemotherapy
*Lumpectomy with or without XRT versus mastectomy - 12 yrs of NSABP data
*Radiation Therapy for DCIS & Invasive cancer - pros & cons
*Current status of axillary node dissection
*Novel chemoprevention approaches
*Novel genetic approaches to therapy

*EXHIBITS BY LEADING COMPANIES
*PRESENTATIONS BY RESEARCHERS ATTENDING MEETING

Registration :
Register by Fax or mail:
Tel and/or FAX: 212-737-3091
EARLY DEADLINE - August 14, 1997 (for lowest rates, starting at $99))
LATE REGISTRATION UNTIL SEPT. 15, 1997




Deadline for Abstracts: August 1, 1997

Email for Requests and Registration: GeneQuest@concentric.net


Posted by: Chris Reed, Vice President Host: 61025d0012ny.concentric.net date: April 22, 97 5:38:57
Generated by meetings and positions 1.0 by Kai Garlipp